Back to Search
Start Over
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing?
- Publication Year :
- 2017
- Subjects :
- 0301 basic medicine
Ledipasvir
Sofosbuvir
Tenofovir
Hepatitis C virus
medicine.disease_cause
Antiviral Agents
Benzimidazole
Drug Administration Schedule
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Pharmacotherapy
medicine
Humans
Protease inhibitor (pharmacology)
030212 general & internal medicine
Antiviral Agent
Fluorenes
Evidence-Based Medicine
Hepatology
business.industry
Gastroenterology
Hepatitis C
Antiretroviral therapy
Virology
Fluorene
Treatment Outcome
030104 developmental biology
chemistry
Sofosbuvir/ledipasvir
Benzimidazoles
Drug Therapy, Combination
Hepatitis C viru
business
Human
Co administration
medicine.drug
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....8804879d43794dfe7d79a965d99d84d3